Eesti - eesti - Ravimiamet

teva pharma b.v. - dutasteriid - pehmekapsel - 0,5mg 50tk; 0,5mg 10tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Euroopa Liit - eesti - EMA (European Medicines Agency)

mylan ireland limited - abirateroonatsetaat - eesnäärmevähk - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Euroopa Liit - eesti - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Eesti - eesti - Ravimiamet

accord healthcare b.v. - dutasteriid - pehmekapsel - 0,5mg 10tk

Eesti - eesti - Ravimiamet

teva pharma b.v. - dutasteriid - pehmekapsel - 0,5mg 28tk

Eesti - eesti - Ravimiamet

teva pharma b.v. - dutasteriid - pehmekapsel - 0,5mg 90tk; 0,5mg 100tk

Eesti - eesti - Ravimiamet

galenicum health s.l.u. - dutasteriid - pehmekapsel - 0,5mg 10tk; 0,5mg 50tk; 0,5mg 90tk; 0,5mg 30tk; 0,5mg 60tk

Eesti - eesti - Ravimiamet

sia elvim - dutasteriid - pehmekapsel - 0,5mg 30tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antitrombootilised ained - prevention of venous thromboembolic events.